Intravascular catheters market seen reaching $15.15 billion by 2030

The intravascular catheters market is projected to grow from $8.42 billion in 2025 to $9.53 billion in 2026, then reach $15.15 billion by 2030, according to The Business Research Company. Growth is tied to hospital admissions, chronic disease care, infection-prevention demand and wider use of home infusion and advanced catheter designs.

Why it matters: - Intravascular catheters are core tools for delivering fluids, medications, blood products and nutrients directly into large veins. - Demand for these devices rises with hospital use, chronic disease treatment and infection-prevention priorities. - The market outlook points to sustained expansion for a basic medical device category with broad use across care settings.

What happened: - The Business Research Company released its Intravascular Catheters Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - The report says the market will grow from $8.42 billion in 2025 to $9.53 billion in 2026. - The report projects the market will reach $15.15 billion by 2030. - The report puts the market on a 12.3% compound annual growth rate through 2030. - North America was the largest regional market in 2025. - Asia-Pacific is forecast to be the fastest-growing region.

The details: - Growth is linked to rising hospitalization rates, greater use of intravenous drug administration, oncology and renal care treatment growth, awareness of catheter-related infections and advances in catheter materials and technology. - The report highlights growing preference for infection-resistant devices, homecare infusion therapies, chronic disease management programs, stronger patient safety protocols and more sophisticated catheter designs. - Emerging trends include safety-engineered catheter systems, antimicrobial-coated catheters, long-term vascular access devices, integrated closed catheter systems and a stronger focus on infection prevention. - Intravascular catheters are described as specialized medical devices typically made with a hollow fiber and an immunoisolating membrane that protects transplanted cells from the bloodstream. - The devices support infusion and sampling during patient care. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report also includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated graphics and tables. - A free sample of the report is available here. - The full report is available here.

Between the lines: - The report ties market growth to broader shifts in care delivery, including more treatment outside hospitals and greater emphasis on reducing device-related infections. - The focus on safety-engineered and antimicrobial products suggests buyers are prioritizing risk reduction as catheter use expands. - The regional split points to mature demand in North America and faster adoption opportunities in Asia-Pacific. - The press release cites a November 2024 American Journal of Managed Care report saying the weekly U.S. hospitalization rate peaked at 13.5 per 100,000 population in early February 2025.

What's next: - The market is expected to keep expanding through 2030 as chronic disease management and home infusion programs scale. - Manufacturers are likely to compete on infection control, product design and longer-term vascular access solutions. - The Business Research Company will continue promoting the report through its sales and contact channels.

The bottom line: - Intravascular catheters are moving from steady demand to faster long-term growth, with infection prevention and home-based care shaping the next phase.